> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OMB Approves 23 FDA Information Collections
- URL: https://www.fdaweb.com/omb-approves-23-fda-information-collections/
- Published: 2021-10-04T12:00:00.000Z
- Updated: 2026-09-14T17:17:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150282

*Federal Register* notice: FDA has announced that 23 information collections have been approved by OMB. They are:  

- Blood Establishment Registration and Product Listing for Manufacturers of Blood and Blood Products and Licensed Devices
- Current Good Manufacturing Practice: Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals
- Irradiation in the Production, Processing, and Handling of Food State Enforcement Notifications
- Veterinary Feed Directive
- Record Retention Requirements for the Soy Protein/Coronary Heart Disease Health Claim
- Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements
- Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications
- Survey of Drug Product Manufacturing, Processing, and Packing Facilities
- Current Good Manufacturing Practices for Blood and Related Regulations for Blood Components; and Requirements for Donor Testing, Donor Notification and ‘‘Lookback’’
- New Animal Drugs for Investigational Use
- Regulations Under the Federal Import Milk Act
- Medical Device Reporting
- New Plant Varieties Intended for Food Use
- Guidance for Industry and FDA Staff; Class II Special Controls: Automated Blood Cell Separator Device Oper-ating by Centrifugal or Filtration Separation Principle
- Prescription Drug Advertisements
- Animal Food Labeling; Declaration of Certifiable Color Additives
- Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Food Service Facility Types
- Food and Cosmetic Export Certificates
- National Agriculture and Food Defense Strategy Survey
- Medical Product Communications That are Consistent With the Food and Drug Administration Required Labeling — Questions and Answers
- Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities Questions and Answers
- Study of Disclosures to Health Care Providers Regarding Data That Do Not Support Unapproved Use of an Approved Prescription Drug
- Medical Conference Attendees’ Observations About Prescription Drug Promotion

To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-10-01/pdf/2021-21386.pdf?ref=fdaweb.com).